Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

J P Gagnon

Showing results (1-10 of 52) with videos related to

Pageof 6
Sort By:
American Heart Journal|April 30, 1999
Proceedings of a symposium: economics and cost-effectiveness in evaluating the value of cardiovascular therapies. What constitutes a useful health economic study for the pharmaceutical industry?J P Gagnon
American Pharmacy|January 1, 1993
Pharmacoeconomics: an emerging role for pharmacistsJ P Gagnon
Journal of the American Pharmaceutical Association|September 1, 1977
Factors affecting pharmacy patronage motives--a literature reviewJ P Gagnon
Journal of the American Pharmaceutical Association|March 1, 1976
Pharmaceutical services--consumer perceptionsJ P Gagnon
American Pharmacy|December 1, 1980
Third-party reimbursement. How did we get where we are today?J P Gagnon
Pharmacy Management Combined with the American Journal of Pharmacy : PM|September 1, 1979
Prescription department cost analysisJ P Gagnon
Topics in Hospital Pharmacy Management|July 10, 1981
Capital budgeting -- evaluation of long-term projectsJ P Gagnon
American Pharmacy|May 1, 1995
Pharmacists and disease managementJ P Gagnon
American Pharmacy|January 1, 1994
Life in pharmacy after health care reformJ P Gagnon
Journal of the American Pharmaceutical Association|October 1, 1977
A framework of rational prescription pricingJ P Gagnon
Pageof 6

Showing results (1-10 of 52) with videos related to

Sort By:
Pageof 6
American Heart Journal|April 30, 1999
Proceedings of a symposium: economics and cost-effectiveness in evaluating the value of cardiovascular therapies. What constitutes a useful health economic study for the pharmaceutical industry?J P Gagnon
American Pharmacy|January 1, 1993
Pharmacoeconomics: an emerging role for pharmacistsJ P Gagnon
Journal of the American Pharmaceutical Association|September 1, 1977
Factors affecting pharmacy patronage motives--a literature reviewJ P Gagnon
Journal of the American Pharmaceutical Association|March 1, 1976
Pharmaceutical services--consumer perceptionsJ P Gagnon
American Pharmacy|December 1, 1980
Third-party reimbursement. How did we get where we are today?J P Gagnon
Pharmacy Management Combined with the American Journal of Pharmacy : PM|September 1, 1979
Prescription department cost analysisJ P Gagnon
Topics in Hospital Pharmacy Management|July 10, 1981
Capital budgeting -- evaluation of long-term projectsJ P Gagnon
American Pharmacy|May 1, 1995
Pharmacists and disease managementJ P Gagnon
American Pharmacy|January 1, 1994
Life in pharmacy after health care reformJ P Gagnon
Journal of the American Pharmaceutical Association|October 1, 1977
A framework of rational prescription pricingJ P Gagnon
Pageof 6